1. Home
  2. VSTM vs GCI Comparison

VSTM vs GCI Comparison

Compare VSTM & GCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • GCI
  • Stock Information
  • Founded
  • VSTM 2010
  • GCI 1997
  • Country
  • VSTM United States
  • GCI United States
  • Employees
  • VSTM N/A
  • GCI N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • GCI Newspapers/Magazines
  • Sector
  • VSTM Health Care
  • GCI Consumer Discretionary
  • Exchange
  • VSTM Nasdaq
  • GCI Nasdaq
  • Market Cap
  • VSTM 662.8M
  • GCI 612.9M
  • IPO Year
  • VSTM 2012
  • GCI N/A
  • Fundamental
  • Price
  • VSTM $9.92
  • GCI $4.10
  • Analyst Decision
  • VSTM Strong Buy
  • GCI Buy
  • Analyst Count
  • VSTM 9
  • GCI 3
  • Target Price
  • VSTM $13.38
  • GCI $5.70
  • AVG Volume (30 Days)
  • VSTM 2.9M
  • GCI 1.5M
  • Earning Date
  • VSTM 11-05-2025
  • GCI 10-30-2025
  • Dividend Yield
  • VSTM N/A
  • GCI N/A
  • EPS Growth
  • VSTM N/A
  • GCI N/A
  • EPS
  • VSTM N/A
  • GCI 0.73
  • Revenue
  • VSTM $2,137,000.00
  • GCI $2,390,148,000.00
  • Revenue This Year
  • VSTM $86.06
  • GCI N/A
  • Revenue Next Year
  • VSTM $395.22
  • GCI N/A
  • P/E Ratio
  • VSTM N/A
  • GCI $5.72
  • Revenue Growth
  • VSTM N/A
  • GCI N/A
  • 52 Week Low
  • VSTM $2.40
  • GCI $2.55
  • 52 Week High
  • VSTM $11.25
  • GCI $5.93
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 66.95
  • GCI 51.42
  • Support Level
  • VSTM $8.71
  • GCI $4.00
  • Resistance Level
  • VSTM $11.25
  • GCI $4.31
  • Average True Range (ATR)
  • VSTM 0.64
  • GCI 0.15
  • MACD
  • VSTM 0.05
  • GCI -0.01
  • Stochastic Oscillator
  • VSTM 64.05
  • GCI 43.24

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About GCI Gannett Co. Inc.

Gannett Co Inc is a digital newspaper company providing local media and marketing solutions in the U.S. The group operates in three segments, Domestic Gannett Media, Newsquest, and Digital Marketing Solutions. The majority of revenue is from the Domestic Gannett Media segment. The company's brands include USA TODAY and more than 250 daily newspapers as well as digital marketing services companies, including ReachLocal, WordStream, and others. The company produces more than 350 annual events, such as themed expos. The company also operates in the U.K. through the U.K. media company Newsquest, providing more than 150 local media brands.

Share on Social Networks: